Opko Health share price logo

Opko Health

NASDAQ: OPK

Small Cap

$1.47

+0.01

(+0.68%)

as on

Opko Health Stock Performance

as on August 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.42
    $1.48
    downward going graph

    3.40%

    Downside

    0.68%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.98
    $1.73
    downward going graph

    33.54%

    Downside

    17.69%

    Upside

    downward going graph

Opko Health share price movements today

Previous Close
$1.46
Open
$1.44
Volume
3.2M
Market Cap
$1.0B
Day's Low - High
$1.42 - $1.48
52 Week Low - High
$0.98 - $1.73

Opko Health Historical Returns

1 Month Return
+ 15.97 %
3 Month Return
+ 25.45 %
1 Year Return
+ 0.73 %
3 Year Return
-20.69 %
5 Year Return
-62.9 %

Opko Health Stock Fundamentals & Key Indicators

Check Opko Health market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

-0.22

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.13%

PE Ratio (TTM)

0

PEG Ratio

93.6471

EBITDA

-78.2M

Revenue (TTM)

587.9M

Profit Margin

-12.40%

Return On Equity TTM

-5.88%

Opko Health vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Opko Health with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.0B-62.9%NA-12.40%NA
BUY$44.7B209.4%-228.5165.30%NA
BUY$43.4B-18.75%39.8162.45%NA
BUY$217.5B5.75%3240.37%0.3%
BUY$142.3B-36.92%36.1158.51%0.7100000000000001%

Stock Returns calculator for Opko Health Stock including INR - Dollar returns

The Opko Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Opko Health investment value today

Current value as on today

₹1,17,999

Returns

₹17,999

(+18%)

Returns from Opko Health Stock

₹7,299 (+7.3%)

Dollar Impact

₹10,699 (+10.7%)

Analyst Recommendation on Opko Health Stock

Based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Opko Health. Average target price of $4.38

Opko Health Share Price Target

Get share price movements and forecasts by analysts on Opko Health.

What analysts predicted

66.44%UPSIDE

Target Price

$4.38

Current Price

$1.47

Analyzed by

3 Analysts

Target

$4.38

Opko Health target price $4.38, a slight upside of 66.44% compared to current price of $1.47. According to 3 analysts rating.

Indian Investors' Interest in Opko Health Stock

Search interest for Opko Health Stock has increased by 1260% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1260% versus previous 30 day period

Opko Health Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
173
182
173
183
149
156
151
148
124
163
Gross Profit
42
51
40
84
22
29
30
44
26
80
Operating Income
-71
-61
14
-33
-67
-59
-53
-38
-51
-6
EBITDA
-49
21
89
73
-34
-69
75
-13
-27
11
Interest Expense
7
8
17
14
15
70
11
11
10
11
Depreciation
25
24
24
24
23
23
22
22
22
22
Income Before Tax
-83
-10
48
34
-73
-162
41
-46
-60
-13
Income Tax Expense
-1
0
23
20
-5
-14
19
-15
-6
-4
Net Income
-81
-10
24
14
-67
-148
21
-31
-54
-8
Net Profit Margin
-47.12%
-5.66%
14.33%
7.64%
-45.09%
-94.66%
14.26%
-21.06%
-44.16%
-5.14%

Opko Health Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,221
966
990
901
1,435
1,774
1,004
863
713
606
Gross Profit
610
345
385
329
541
581
288
318
311
128
Operating Income
-73
-276
-171
-274
57
18
-226
-157
-152
-218
EBITDA
7
-163
-68
-189
155
83
-270
-65
135
-41
Interest Expense
7
6
11
21
21
18
12
13
47
108
Depreciation
-
102
97
93
85
50
108
105
98
91
Income Before Tax
-73
-271
-177
-304
48
-14
-391
-184
-10
-241
Income Tax Expense
-56
18
-38
7
17
15
-63
4
42
-15
Net Income
-48
-305
-153
-314
30
-30
-328
-188
-53
-225
Net Profit Margin
-3.96%
-31.60%
-15.45%
-34.92%
2.13%
-1.70%
-32.70%
-21.87%
-7.46%
-37.19%

Opko Health Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-10
24
14
-67
-148
21
-31
-54
-8
Operating Cash Flow
-26
-77
-44
-34
-83
-34
-25
-19
-43
Investing Cash Flow
-7
247
115
40
-2
194
-2
-1
15
Financing Cash Flow
-2
206
-40
-4
-79
-16
-18
-5
-13
Change in Cash
-35
379
25
4
-164
143
-46
-27
-41

Opko Health Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-305
-153
-314
30
-30
-328
-188
-53
-225
Operating Cash Flow
-92
-109
-172
39
38
-95
-28
-183
-178
Investing Cash Flow
-46
-26
-13
-18
35
91
-18
352
230
Financing Cash Flow
61
140
175
-35
-10
22
-11
184
-118
Change in Cash
-77
4
-11
-13
62
18
-57
349
-62

Mutual Funds that own Opko Health Stock

Check out the Mutual Funds with significant holdings in Opko Health.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.389666%
25298039
Fidelity Concord Street Trust
0.619443%
4623080
Fidelity Salem Street Trust
0.612093%
4568227
Goldman Sachs Trust
0.367848%
2745360
VANGUARD SCOTTSDALE FUNDS
0.318342%
2375881

Global Institutional Holdings in Opko Health

Funds
Holdings
Vanguard
3.97%
iShares
2.65%
KSM
0.6%
Harel Sal
0.39%
MTF
0.39%

Opko Health News & Key Events

  • img

    Today's Timeline - 29 October

    Wed, 09:30 PM

    -

    ModeX Therapeutics enters collaboration with Regeneron, receiving $7 million upfront and potential milestone payments exceeding $200 million per molecule.

Insights on Opko Health

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -54.84M → -8.41M (in $), with an average increase of 551.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 124.19M → 163.57M (in $), with an average increase of 24.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, OPK stock has moved up by 4.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 518.0% return, outperforming this stock by 534.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Natera, Inc. Common Stock has given 102.4% return, outperforming this stock by 97.4%

About Opko Health

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.
OrganisationOpko Health
Headquarters4400 Biscayne Boulevard, Miami, FL, United States, 33137
IndustryDiagnostics & Research
CEODr. Phillip Frost M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Opko Health

Name

Title

Dr. Elias Adam Zerhouni M.D.

President & Vice Chairman of the Board

Mr. Adam E. Logal

Senior VP, CFO, Chief Accounting Officer & Treasurer

Mr. Steven D. Rubin Esq., J.D.

Executive VP of Administration & Director

Dr. Gary J. Nabel M.D., Ph.D.

Chief Innovation Officer & Director

Mr. Giovanni Abbadessa M.D., Ph.D.

Chief Medical Officer of ModeX

Dr. John R. Mascola M.D.

Chief Scientific Officer of ModeX

Mr. Gene Yau

Head of Business Development

Dr. Phillip Frost M.D., Ph.D.

Chairman of the Board & CEO

Dr. Jane H. Hsiao M.B.A., Ph.D.

Vice Chairman of the Board & Chief Technical Officer

Dr. Akhtar Ashfaq FACP, FASN, M.D.

Senior Vice President of Clinical Research & Development and Medical Affairs - Opko Renal

FAQs

What is Opko Health share price today?

Opko Health share price today is $1.47 as on at the close of the market. Opko Health share today touched a day high of $1.48 and a low of $1.42.

What is the 52 week high and 52 week low for Opko Health share?

Opko Health share touched a 52 week high of $1.73 on and a 52 week low of $0.98 on . Opko Health stock price today i.e. is closed at $1.47,which is 15.03% down from its 52 week high and 50.48% up from its 52 week low.

What is Opko Health's market capitalisation today?

Opko Health market capitalisation is $0.00T as on .

How to invest in Opko Health Stock (OPK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Opko Health on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Opko Health Shares that will get you 1.0204 shares as per Opko Health share price of $1.47 per share as on August 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Opko Health Stock (OPK) from India?

Indian investors can start investing in Opko Health (OPK) shares with as little as ₹95.695 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.95 in Opko Health stock (as per the Rupee-Dollar exchange rate as on ). Based on Opko Health share’s latest price of $1.47 as on August 21, 2026 at 1:29 am IST, you will get 6.8027 shares of Opko Health. Learn more about fractional shares .

What are the returns that Opko Health has given to Indian investors in the last 5 years?

Opko Health stock has given -62.9% share price returns and 28.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?